Development of a quantitative-competitive PCR for quantification of human cytomegalovirus load and comparison with antigenaemia, viraemia and pp67 RNA detection by nucleic acid sequence-based amplification

Panminerva Medica

Volumn 48, Issue 2, 2006, Pages 119-127

  Bergallo, M ^a   Costa, C ^a   Tarallo, S ^a   Daniele, R ^a   Merlino, C ^a   Segoloni, G P ^b   Ponzi, A Negro ^a   Cavallo, R ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cytomegalovirus; Nucleic acid; Viremia

Indexed keywords

CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; MATRIX PROTEIN; MESSENGER RNA; PHOSPHOPROTEIN; PP67 PROTEIN, HUMAN CYTOMEGALOVIRUS; VIRUS ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; CYTOMEGALOVIRUS; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; VIREMIA; VIRUS LOAD;

ADULT; AGED; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRAL LOAD; VIRAL MATRIX PROTEINS; VIREMIA;

EID: 33750569151     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Sagedal S, Hartmann A, Rollag H. The impact of early cytomegalovirus infection and disease in renal transplant recipients. Clin Microbiol Infect 2005;11:518-30.
2. Sagedal S, Nordal KP, Hartmann A, Degré M, Holler E, Foss A et al. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients. Transplantation 2000;70:1166-74.
3. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741-51.
4. Yan SS, Fedorko DP. Recent advances in laboratory diagnosis of human cytomegalovirus infection. Clin Applied Immunol Rev 2002;2:155-67.
5. Rollag H, Sagedal S, Kristiansen KI, Kvale D, Holler E, Degré M et al. Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients. Clin Microbiol Infect 2002;8:431-4.
6. Kusne S, Grossi P, Irish W, St George K, Rinaldo J, Rakela J et al. Cytomegalovirus pp65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1999;68:1125-31.
7. Blank BSN, Meenhorst PL, Mulder JW, Weverling GJ, Putter H, Pauw W et al. Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients. J Clin Microbiol 2000;38:563-9.
8. The TH, Van der Ploeg M, Van der Berg AP, Vlieger AM, Van der Giessen M, Van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes. A review of antigenemia assay and polymerase chain reaction. Transplantation 1992;54:193-8.
9. Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S et al. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients. J Med Virol 2004;73:412-8.
10. Miller MJ, Bovey S, Pado K, Bruckner DA, Wagar EA. Application of PCR to multiple specimen types for diagnosis of cytomegalovirus infection: comparison with cell culture and shell vial assay. J Clin Microbiol 1994;32:5-10.
11. Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant patients with CMV disease. Transplantation 2002;73:968-73.
12. Boeckh M, Huang M, Ferrenberg J, Stevens-Ayers T, Stensland L, Nichols WG et al. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J Clin Microbiol 2004;42:1142-8.
13. Caliendo AM, St. George K, Allega J, Bullotta AC, Gilbane L, Rinaldo CR. Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays. J Clin Microbiol 2002;40:1581-6.
14. Gault E, Michel Y, Dehée A, Belabani C, Nicolas J-C, Garbarg-Chenon A. Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol 2001;39:772-5.
15. Gouarin S, Vabret A, Gault E, Petitjean J, Regeasse A, Hurault de Ligny B et al. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay. J Clin Virol 2004;29:194-201.
16. Griscelli F, Barrois M, Chauvin S, Lastere S, Bellet D, Bourhis J-H. Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J Clin Microbiol 2001;39:4362-9.
17. Hadaya K, Wunderli W, Deffernez C, Martin P-Y, Mentha G, Binet I et al. Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay. J Clin Microbiol 2003;41:3757-64.
18. Halwachs-Baumann G, Wilders-Truschnig M, Enzinger G, Eibl M, Linkesch W, Dornbusch HJ et al. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays. J Clin Virol 2001;20:49-57.
19. Kalpoe JS, Kroes ACM, de Jong MD, Schinkel J, de Brouwer CS, Beersma MFC et al. Validation of clinical application of CMV plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 2004;42:1498-504.
20. Blank BSN, Meenhorst PL, Pauw W, Mulder JW, van Dijk WC, Smits PHM et al. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients. J Clin Virol 2002;25:29-38.
21. Blok MJ, Christiaans MHL, Goossens VJ, van Hooff JP, Sillekens P, Middeldorp JM et al. A. Early detection of infection after kidney transplantation by NASBA. Transplantation 1999;67:1274-7.
22. Diaz-Mitoma F, Leger C, Miller H, Giulivi A, Frost R, Shaw L et al. Comparison of DNA amplification, mRNA amplification, and DNA hybridization techniques for detection of cytomegalovirus in bone marrow transplant recipients. J Clin Microbiol 2003;41:5159-66.
23. Gerna G, Baldanti F, Lilleri D, Parea M, Alessandrino E, Pagani A et al. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients. J Clin Microbiol 2000;38:1845-53.
24. Greijer AE, Verschuuren EAM, Harmsen MC, Dekkers CAJ, Adriaanse HMA, The TH et al. Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification. J Clin Microbiol 2001;39:251-9.
25. Greijer AE, Adriaanse HMA, Dekkers CAJ, Middeldorp JMM. Multiplex real-time NASBA for monitoring expression dynamics of human cytomegalovirus encoded IE1 and pp67 RNA. J Clin Virol 2002;24:57-66.
26. Merlino C, Bergallo M, Gregori G, Sinesi F, Bollero C, Cavallo R. HCMV pp67-mRNA detection by nucleic acid sequence-based amplification in renal transplant patients. Microbiologica 2002;25:1-8.
27. Mengelle C, Sandres-Sauné K, Pasquier C, Rostaing L, Mansuy J-M, Marty M et al. Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J Clin Microbiol 2003;41:3840-5.
28. Mengelle C, Pasquier C, Rostaing L, Sandres-Saunè K, Puel J, Berges L et al. Commutation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia. J Med Virol 2003;69:225-31.
29. Mengoli C, Cusinato R, Biasolo MA, Cesaro S, Parolin C, Palù G. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection. J Med Virol 2004;74:78-84.
30. Meyer-Koenig U, Weidmann M, Kirste G, Hufert FT. Cytomegalovirus infection in organ-transplant recipients: diagnostic value of pp65 antigen test, qualitative polymerase chain reaction (PCR) and quantitative Taqman PCR. Transplantation 2004;77:1692-8.
31. Tanaka N, Kimura H, Iida K, Saito Y, Tsuge I, Yoshimi A et al. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol 2000;60:455-62.
32. Cavallo R, Sinesi F, Re D, Piovesan F, Fora R, Lembo D et al. Diagnosi precoce di infezione da HCMV in pazienti sottoposti a trapianto renale. G Batteriol Virol Immunol 1994;76:29-42.
33. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-Van Dillen PME, Van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
34. Kievits T, Van Gessen B, Van Strijp D, Schukkink R, Dircks M, Adriaanse H et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods 1991;35:273-86.
35. Fenner TE, Garweg J, Hufert FT, Boehnke, Schmitz H. Diagnisis of human cytomegalovirus-induced retinitis in human immunodeficiency virus type 1-infected subjects by using the polymerase chain reaction. J Clin Microbiol 1991;29:2621-2.
36. Bergallo M, Merlino C, Daniele R, Sinesi F, Fumagalli M, Negro Ponzi A et al. Double-step PCR assay to quantify Epstein-Barr viral load in peripheral blood. Mol Biotechnol 2004;27:187-95.
37. Mendez J, Espy M, Smith TF, Wilson J, Wiesner R, Paya C. Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation. Transplantation 1998;65:1477-81.
38. Tong CJ, Cuevas LE, Williams H, Bakran A. Prediction and diagnosis of cytomegalovirus disease in renal transplant recipients using qualitative and quantitative polymerase chain reaction. Transplantation 2000;69:985-91.
39. Piiparinen H, Höckerstedt K, Lappalainen M, Suni J, Lautenschlager I. Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients. J Clin Microbiol 2002;40:2945-52.
40. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res 1996;6:995-1001.
41. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
42. Diviacco S, Norio P, Zentilin L, Menzo S, Clementi M, Biamonti G et al. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene 1992;122:313-20.
43. Fox JC, Griffiths PD, Emery VC. Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J Gen Virol 1992;73:2405-8.
44. Menzo S, Bagnarelli P, Giacca M, Manzin A, Varaldo PE, Clementi M. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol 1992;30:1742-5.
45. Emery WC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. Application of viral load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000;355:2032-6.
46. Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S et al. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients. J Med Virol 2004;73:412-8.
47. Li H, Dummer JS, Estes WR, Meng S, Wright PF, Tang YW. Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 2003;41:187-91.
48. Piiparinen H, Höckerstedt K, Grönhagen-Riska C, Lappalainen M, Suni J, Lautenschlager I. Comparison of plasma polymerase chain reaction and pp65-antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients. J Clin Virol 2001;22:111-6.